AU565479B2 – Simultaneous production of two or more gene products
– Google Patents
AU565479B2 – Simultaneous production of two or more gene products
– Google Patents
Simultaneous production of two or more gene products
Info
Publication number
AU565479B2
AU565479B2
AU15044/83A
AU1504483A
AU565479B2
AU 565479 B2
AU565479 B2
AU 565479B2
AU 15044/83 A
AU15044/83 A
AU 15044/83A
AU 1504483 A
AU1504483 A
AU 1504483A
AU 565479 B2
AU565479 B2
AU 565479B2
Authority
AU
Australia
Prior art keywords
gene products
simultaneous production
alpha interferon
gene
taught
Prior art date
1982-05-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15044/83A
Other versions
AU1504483A
(en
Inventor
Mag. Gunther Adolf
Gerhard Bodo
Marc-Bruce Dworkin
Eva Dworkin-Rastl
Peter Meindl
Peter Swetly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1982-05-28
Filing date
1983-05-27
Publication date
1987-09-17
Family has litigation
First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=6164725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU565479(B2)
“Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
1983-05-27
Application filed by Dr Karl Thomae GmbH
filed
Critical
Dr Karl Thomae GmbH
1983-12-01
Publication of AU1504483A
publication
Critical
patent/AU1504483A/en
1987-09-17
Application granted
granted
Critical
1987-09-17
Publication of AU565479B2
publication
Critical
patent/AU565479B2/en
2003-05-27
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C12N15/09—Recombinant DNA-technology
C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/52—Cytokines; Lymphokines; Interferons
C07K14/555—Interferons [IFN]
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S930/00—Peptide or protein sequence
Y10S930/01—Peptide or protein sequence
Y10S930/14—Lymphokine; related peptides
Y10S930/142—Interferon
Abstract
A novel species of alpha interferon is taught. The alpha interferon amino acid sequence is disclosed and a gene corresponding thereto. The alpha interferon gene is expressed in Escherichia coli.
AU15044/83A
1982-05-28
1983-05-27
Simultaneous production of two or more gene products
Ceased
AU565479B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
DE32201168
1982-05-28
DE19823220116
DE3220116A1
(en)
1982-05-28
1982-05-28
MICROBIOLOGICALLY MANUFACTURED (ALPHA) AND SS INTERFERONES, DNA SEQUENCES CODING FOR THESE INTERFERONES, MICROORGANISMS CONTAINING THIS GENETIC INFORMATION, AND METHOD FOR THE PRODUCTION THEREOF
Publications (2)
Publication Number
Publication Date
AU1504483A
AU1504483A
(en)
1983-12-01
AU565479B2
true
AU565479B2
(en)
1987-09-17
Family
ID=6164725
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU15044/83A
Ceased
AU565479B2
(en)
1982-05-28
1983-05-27
Simultaneous production of two or more gene products
Country Status (22)
Country
Link
US
(1)
US4820638A
(en)
EP
(1)
EP0095702B1
(en)
JP
(2)
JPH0774238B2
(en)
KR
(1)
KR920006349B1
(en)
AT
(1)
ATE42114T1
(en)
AU
(1)
AU565479B2
(en)
DD
(1)
DD211359C4
(en)
DE
(2)
DE3220116A1
(en)
DK
(1)
DK164742C
(en)
ES
(2)
ES8403522A1
(en)
FI
(1)
FI82072C
(en)
GR
(1)
GR79236B
(en)
HK
(1)
HK112893A
(en)
HU
(1)
HU196452B
(en)
IL
(1)
IL68790A
(en)
MX
(1)
MX9202815A
(en)
NO
(1)
NO168538C
(en)
NZ
(1)
NZ204384A
(en)
SG
(1)
SG38692G
(en)
SU
(1)
SU1346048A3
(en)
UA
(1)
UA8037A1
(en)
ZA
(1)
ZA833845B
(en)
Families Citing this family (32)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE3247922A1
(en)
*
1982-12-24
1984-06-28
Boehringer Ingelheim International GmbH, 6507 Ingelheim
DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS
DE3515336C2
(en)
*
1985-04-27
1994-01-20
Boehringer Ingelheim Int
Process for the preparation and purification of â-interferon
US4709324A
(en)
*
1985-11-27
1987-11-24
Motorola, Inc.
Data processor control unit having an interrupt service using instruction prefetch redirection
CA2025180A1
(en)
*
1989-10-12
1991-04-13
William G. Weisburg
Nucleic acid probes and methods for detecting pathogenic candida yeasts
US6685933B1
(en)
*
1998-07-28
2004-02-03
The United States Of America As Represented By The Department Of Health And Human Services
Interferon α hybrids
CA2427194A1
(en)
*
2000-11-03
2002-05-10
Biomedicines, Inc.
Method for short-term and long-term drug dosimetry
FR2817559B1
(en)
*
2000-12-06
2003-12-12
Genodyssee
METHOD FOR DETERMINING ONE OR MORE FUNCTIONAL POLYMORPHISM (S) IN THE NUCLEIC SEQUENCE OF A PRESELECTED FUNCTIONAL “CANDIDATE” GENE AND ITS APPLICATIONS
FR2821625B1
(en)
*
2001-03-01
2003-05-16
Genodyssee
NOVEL POLYNUCLEOTIDES COMPRISING FUNCTIONAL SNP-TYPE POLYMORPHISM IN THE NUCLEOTIDE SEQUENCE OF THE IFN-ALPHA-2 GENE AS WELL AS NEW POLYPEPTIDES ENCODED BY THESE POLYNUCLEOTIDES AND THEIR THERAPEUTIC USES
FR2823220B1
(en)
*
2001-04-04
2003-12-12
Genodyssee
NOVEL ERYTHROPOIETIN (EPO) POLYNUCLEOTIDES AND POLYPEPTIDES
ATE481135T1
(en)
*
2001-11-09
2010-10-15
Intarcia Therapeutics Inc
COMBINATION THERAPY WITH OMEGA INTERFERON FOR THE TREATMENT OF HEPATITIS C VIRUS OR YELLOW FEVER VIRUS INFECTIONS
US20040063912A1
(en)
*
2002-03-15
2004-04-01
The Brigham And Women’s Hospital, Inc.
Central airway administration for systemic delivery of therapeutics
WO2003099320A1
(en)
2002-05-24
2003-12-04
Zensun (Shanghai) Sci-Tech.Ltd
Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
DE60332358D1
(en)
*
2002-09-09
2010-06-10
Hanall Pharmaceutical Co Ltd
PROTEASE-RESISTANT MODIFIED INTERFERON ALPHA POLYPEPTIDE
EP1740608B1
(en)
2004-02-02
2012-02-22
Ambrx, Inc.
Modified human growth hormone polypeptides and their uses
US11246913B2
(en)
2005-02-03
2022-02-15
Intarcia Therapeutics, Inc.
Suspension formulation comprising an insulinotropic peptide
WO2006083761A2
(en)
2005-02-03
2006-08-10
Alza Corporation
Solvent/polymer solutions as suspension vehicles
JP5143131B2
(en)
2006-05-30
2013-02-13
インターシア セラピューティクス，インコーポレイティド
Two-piece internal channel flow modulator for osmotic delivery system
EP2049081B1
(en)
2006-08-09
2012-11-14
Intarcia Therapeutics, Inc.
Osmotic delivery systems and piston assemblies
US20080260820A1
(en)
*
2007-04-19
2008-10-23
Gilles Borrelly
Oral dosage formulations of protease-resistant polypeptides
MX2009011123A
(en)
2007-04-23
2009-11-02
Intarcia Therapeutics Inc
Suspension formulations of insulinotropic peptides and uses thereof.
WO2009102467A2
(en)
2008-02-13
2009-08-20
Intarcia Therapeutics, Inc.
Devices, formulations, and methods for delivery of multiple beneficial agents
AU2010298733B2
(en)
2009-09-28
2014-10-09
Intarcia Therapeutics, Inc.
Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1
(en)
2011-02-16
2012-08-16
Intarcia Therapeutics, Inc.
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013024156A2
(en)
2011-08-17
2013-02-21
INSERM (Institut National de la Santé et de la Recherche Médicale)
Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1
(en)
2011-08-17
2013-02-21
INSERM (Institut National de la Santé et de la Recherche Médicale)
Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1
(en)
2012-08-31
2014-03-06
INSERM (Institut National de la Santé et de la Recherche Médicale)
Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
US9889085B1
(en)
2014-09-30
2018-02-13
Intarcia Therapeutics, Inc.
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2987766A1
(en)
2015-06-03
2016-12-08
Intarcia Therapeutics, Inc.
Implant placement and removal systems
MX2018014016A
(en)
2016-05-16
2019-08-01
Intarcia Therapeutics Inc
Glucagon-receptor selective polypeptides and methods of use thereof.
USD840030S1
(en)
2016-06-02
2019-02-05
Intarcia Therapeutics, Inc.
Implant placement guide
USD860451S1
(en)
2016-06-02
2019-09-17
Intarcia Therapeutics, Inc.
Implant removal tool
EP3565580A1
(en)
2017-01-03
2019-11-13
Intarcia Therapeutics, Inc
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
Family Cites Families (12)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE2906160A1
(en)
*
1979-02-17
1980-09-04
Thomae Gmbh Dr K
Interferon prodn. – using stimulators to increase yields
AU538665B2
(en)
*
1979-10-30
1984-08-23
Juridical Foundation, Japanese Foundation For Cancer Research
Human interferon dna
IL58765A
(en)
*
1979-11-21
1986-09-30
Yeda Res & Dev
Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A
(en)
*
1980-01-08
1985-07-23
Biogen N.V.
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
FI86558C
(en)
*
1980-01-08
1992-09-10
Biogen Inc
DNA sequences, recombinant DNA molecules and methods for producing human-type interferon and selection of the DNA sequence
GB2068970B
(en)
*
1980-02-06
1983-06-22
Searle & Co
Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005897A1
(en)
*
1980-02-16
1981-09-03
Hoechst Ag, 6000 Frankfurt
GENERAL PRODUCT OF A HIGHER ORGANISM FROM A MICROORGANISM CONTAINING THIS GENE
DE3005843A1
(en)
*
1980-02-16
1981-09-10
Hoechst Ag, 6000 Frankfurt
GENERAL PRODUCT OF A HIGHER ORGANISM FROM A MICROORGANISM CONTAINING THIS GENE
ES8302778A1
(en)
*
1980-11-10
1983-02-01
Genentech Inc
Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them.
DE3106982A1
(en)
*
1981-02-25
1982-09-09
Dr. Karl Thomae Gmbh, 7950 Biberach
“NEW TRIDECADEOXYNUCLEOTIDE, PROCESS FOR ITS PRODUCTION AND USE”
IL63327A
(en)
*
1981-07-16
1985-11-29
Yeda Res & Dev
Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
GB2108510B
(en)
*
1981-10-03
1984-12-12
Ciba Geigy Ag
Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
1982
1982-05-28
DE
DE19823220116
patent/DE3220116A1/en
active
Granted
1983
1983-05-19
US
US06/495,944
patent/US4820638A/en
not_active
Expired – Fee Related
1983-05-23
FI
FI831818A
patent/FI82072C/en
not_active
IP Right Cessation
1983-05-24
EP
EP83105116A
patent/EP0095702B1/en
not_active
Expired
1983-05-24
DE
DE8383105116T
patent/DE3379591D1/en
not_active
Expired
1983-05-24
AT
AT83105116T
patent/ATE42114T1/en
not_active
IP Right Cessation
1983-05-24
GR
GR71447A
patent/GR79236B/el
unknown
1983-05-26
DD
DD83251287A
patent/DD211359C4/en
not_active
IP Right Cessation
1983-05-26
IL
IL68790A
patent/IL68790A/en
unknown
1983-05-27
DK
DK239383A
patent/DK164742C/en
not_active
IP Right Cessation
1983-05-27
HU
HU831890A
patent/HU196452B/en
not_active
IP Right Cessation
1983-05-27
UA
UA3598429A
patent/UA8037A1/en
unknown
1983-05-27
ZA
ZA833845A
patent/ZA833845B/en
unknown
1983-05-27
JP
JP58093886A
patent/JPH0774238B2/en
not_active
Expired – Lifetime
1983-05-27
NO
NO831903A
patent/NO168538C/en
unknown
1983-05-27
ES
ES522762A
patent/ES8403522A1/en
not_active
Expired
1983-05-27
AU
AU15044/83A
patent/AU565479B2/en
not_active
Ceased
1983-05-27
SU
SU833598429A
patent/SU1346048A3/en
active
1983-05-27
NZ
NZ204384A
patent/NZ204384A/en
unknown
1983-05-28
KR
KR1019830002362A
patent/KR920006349B1/en
not_active
IP Right Cessation
1984
1984-02-01
ES
ES529360A
patent/ES529360A0/en
active
Granted
1992
1992-04-07
SG
SG386/92A
patent/SG38692G/en
unknown
1992-06-12
MX
MX9202815A
patent/MX9202815A/en
unknown
1993
1993-03-22
JP
JP5062065A
patent/JP2558422B2/en
not_active
Expired – Lifetime
1993-10-21
HK
HK1128/93A
patent/HK112893A/en
not_active
IP Right Cessation
Also Published As
Publication number
Publication date
HU196452B
(en)
1988-11-28
NZ204384A
(en)
1986-11-12
NO831903L
(en)
1983-11-29
FI82072B
(en)
1990-09-28
ES522762A0
(en)
1984-03-16
DE3220116A1
(en)
1983-12-01
NO168538B
(en)
1991-11-25
EP0095702B1
(en)
1989-04-12
DK239383D0
(en)
1983-05-27
JP2558422B2
(en)
1996-11-27
HK112893A
(en)
1993-10-29
UA8037A1
(en)
1995-12-26
JPH0678774A
(en)
1994-03-22
EP0095702A1
(en)
1983-12-07
US4820638A
(en)
1989-04-11
ZA833845B
(en)
1985-01-30
JPH0774238B2
(en)
1995-08-09
SU1346048A3
(en)
1987-10-15
JPS5925689A
(en)
1984-02-09
ATE42114T1
(en)
1989-04-15
DK164742C
(en)
1992-12-28
ES8500321A1
(en)
1984-10-01
FI831818A0
(en)
1983-05-23
GR79236B
(en)
1984-10-22
IL68790A
(en)
1991-06-10
FI831818L
(en)
1983-11-29
DE3379591D1
(en)
1989-05-18
AU1504483A
(en)
1983-12-01
DE3220116C2
(en)
1993-02-18
NO168538C
(en)
1992-03-04
IL68790A0
(en)
1983-09-30
DK239383A
(en)
1983-11-29
KR840004944A
(en)
1984-10-31
DK164742B
(en)
1992-08-10
MX9202815A
(en)
1992-06-30
FI82072C
(en)
1991-01-10
DD211359C4
(en)
1986-09-24
DD211359A5
(en)
1984-07-11
KR920006349B1
(en)
1992-08-03
ES529360A0
(en)
1984-10-01
SG38692G
(en)
1992-09-04
ES8403522A1
(en)
1984-03-16
Similar Documents
Publication
Publication Date
Title
AU565479B2
(en)
1987-09-17
Simultaneous production of two or more gene products
DE3065039D1
(en)
1983-11-03
Total enzymatic hydrolysate of lactoserum proteins, production and applications
AU574323B2
(en)
1988-07-07
Yeast expression of interferon and other proteins
AU6733487A
(en)
1987-06-02
Mammalian interleukin-4
AU555175B2
(en)
1986-09-18
Recombinant dna production of rennins
AU600300B2
(en)
1990-08-09
Polyfluoropolyethers having pendant perfluoroalkoxy groups
AU6502986A
(en)
1987-05-14
Human lysozyme
AU570572B2
(en)
1988-03-17
4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
AU575725B2
(en)
1988-08-04
Improved protein hydrolysate
AU3107684A
(en)
1985-02-07
Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production
DE3572441D1
(en)
1989-09-28
Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
AU3747185A
(en)
1985-06-26
Synthetic polypeptide corresponding to a portion of the heat -labile enterotoxin of escherichia coli, compositions and methods therewith
AU1704988A
(en)
1988-12-02
Peptide production by protein engineering
AU1768188A
(en)
1988-12-22
Pharmaceutical compositions
AU575331B2
(en)
1988-07-28
Improved e. coli plasmid containing modified 5' cipoprotein sequence
EP0146903A3
(en)
1987-07-22
Production of a vector encoding a novel hybrid interferon species
AU7470681A
(en)
1982-03-04
Glicentin related purified peptide having 30 amino acids
None